VA gets green light to prescribe controlled drugs via telemedicine to veterans

What it does

This bill allows VA doctors and other licensed health care professionals to prescribe and deliver controlled medications (like pain relievers or anxiety drugs) to veterans via telemedicine—video or phone—without requiring an in-person visit first, as long as the provider is licensed, acting in good faith, and the medication serves a legitimate medical purpose. The VA Secretary must write rules governing how this works, and all federal drug laws still apply.

Why we flagged it

The bill's sole operative purpose is to expand telemedicine authority for VA providers delivering controlled medications to veterans. It is a straightforward health-access measure with no riders or hidden provisions.

What the text implies

• Telemedicine prescribing of controlled substances may increase medication access for rural and homebound veterans, but could also increase risk of inappropriate prescribing or diversion if VA oversight and clinical protocols are weak.
• The bill defers to VA Secretary to write implementing regulations; the actual safety and appropriateness of telemedicine controlled-substance delivery will depend entirely on the quality and stringency of those rules, which are not specified here.
• Removes the in-person-exam requirement, which was a traditional safeguard against remote prescribing abuse; the bill relies on provider licensing, good-faith judgment, and 'legitimate medical purpose' as substitutes—a weaker standard than prior contact.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Veterans gain expanded access to controlled medications without travel burden or delay, improving convenience and continuity of care for rural and mobility-limited populations. The bill preserves all federal drug-control safeguards and requires VA oversight, so the public-health risk is minimal.

Named in the bill

Department of Veterans Affairs, VA health care professionals, Veterans, Controlled Substances Act, Federal Food, Drug, and Cosmetic Act, Comprehensive Drug Abuse Prevention and Control Act of 1970

Where it stands

28 cosponsors: 15 Democrats, 13 Republicans.

• Feb 6, 2025 — Introduced · Congress.gov: “Introduced in House”
• Feb 6, 2025 — Referred to House Committee on Veterans' Affairs and Senate Committee on Veterans' Affairs · Congress.gov: “Referred to the House Committee on Veterans' Affairs”
• Mar 12, 2025 — Hearing held · Congress.gov: “Subcommittee Hearings Held”
• Mar 25, 2025 — Markup held in committee · Congress.gov: “Subcommittee Consideration and Mark-up Session Held”
• Jul 29, 2025 — Reported out of committee · Congress.gov: “Placed on the Union Calendar, Calendar No. 179”
• Sep 15, 2025 — Passed the House · Congress.gov: “On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4279)”
• Sep 15, 2025 — Floor vote scheduled · Congress.gov: “Mr. Bost moved to suspend the rules and pass the bill, as amended”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

3 lobbying clients named this bill on 6 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $1,039,165 in lobbying spend. A filing names 95 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 61% of bills with at least one filing.

Steve Womack, the sponsor, reported $925,850 in PAC receipts in the 2026 cycle.

• American Psychiatric Association — $529,365 on 2 filings
• Disabled American Veterans — $310,451 on 2 filings
• Paralyzed Veterans of America — $199,349 on 2 filings

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.